Wiebke Rösler

6PUBLICATIONS
17CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Humoural immunology and immunochemistryOther agricultural, veterinary and food sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 17, 2026
Class 3 MAP2K1 mutations are associated with frequent relapse and multiple treatment lines in multi-system Langerhans cell histiocytosis.

|Jul 25, 2025
Prophylactic Tocilizumab prior to infusion of CD19 CAR T-cells reduces therapy-related complications in older lymphoma patients.

Sebastian M Stolz, Albulena Musa, Adrian Bachofner

|Jul 08, 2024
Efficacy of thrombopoietin receptor agonists versus rituximab in non-responsive immune thrombocytopenia-A single centre retrospective analysis.

Sebastian M Stolz, Rahel Schwotzer, Wiebke Rösler

|May 23, 2024
B-cell maturation antigen-directed bispecific antibodies in plasmablastic lymphoma.

Kevin D Hofer, Nathan Wolfensberger, Adrian Bachofner

|May 17, 2024
Distinct [18F]FDG-PET imaging features of a newly recognized and yet uncharacterized RDD-ECD overlap disease entity.

Martin W Huellner, Marco M Bühler, Viktor H Kölzer

|Jun 13, 2022
GOALs in relapsed DLBCL.

Wiebke Rösler, Thorsten Zenz

Pageof 1

Frequent Collaborators

3 joint publications

Kevin D Hofer

2 joint publications

Martin W Huellner

1 joint publications

Thorsten Zenz

1 joint publications

Marco M Bühler